Bayer Financial Statements From 2010 to 2024
| BAYZF Stock | USD 20.83 0.02 0.1% |
Check Bayer AG financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bayer AG's main balance sheet or income statement drivers, such as , as well as many indicators such as . Bayer financial statements analysis is a perfect complement when working with Bayer AG Valuation or Volatility modules.
Bayer |
Bayer AG Company Operating Margin Analysis
Bayer AG's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Bayer AG Operating Margin | 0.23 % |
Most of Bayer AG's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bayer AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Bayer AG has an Operating Margin of 0.2287%. This is 100.65% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The operating margin for all United States stocks is 104.15% lower than that of the firm.
Bayer AG Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bayer AG's current stock value. Our valuation model uses many indicators to compare Bayer AG value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bayer AG competition to find correlations between indicators driving Bayer AG's intrinsic value. More Info.Bayer AG is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bayer AG is roughly 2.26 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bayer AG's earnings, one of the primary drivers of an investment's value.About Bayer AG Financial Statements
Bayer AG stakeholders use historical fundamental indicators, such as Bayer AG's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bayer AG investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bayer AG's assets and liabilities are reflected in the revenues and expenses on Bayer AG's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bayer AG. Please read more on our technical analysis and fundamental analysis pages.
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Ag is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Bayer Pink Sheet
Bayer AG financial ratios help investors to determine whether Bayer Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer AG security.